Daniella Ishimaru

Title: Daniella Ishimaru: Innovator in Lipid Nanoparticle Technologies

Introduction

Daniella Ishimaru is a prominent inventor based in Mountain View, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of lipid nanoparticle compositions for therapeutic applications. With a total of 3 patents, her work focuses on innovative methods for delivering essential treatments to patients.

Latest Patents

Daniella's latest patents include groundbreaking technologies. One of her notable patents is for lipid nanoparticle compositions and their uses. This patent provides methods for delivering lipid nanoparticles (LNPs) to lung cells of subjects suffering from or at risk for primary ciliary dyskinesia (PCD). The method involves nebulizing a liquid pharmaceutical composition to generate an aerosolized pharmaceutical composition, which is then administered to the subject. Another significant patent involves polynucleotide compositions, related formulations, and methods of use. This patent discloses compositions of polynucleotide(s) that may encode for a cystic fibrosis transmembrane conductance regulator (CFTR) protein or a functional fragment thereof. The polynucleotide can be assembled with a lipid composition for targeted delivery to a cell or organ, such as a lung cell.

Career Highlights

Daniella currently works at Recode Therapeutics, Inc., where she continues to advance her research and development efforts. Her innovative approaches have positioned her as a key figure in the biotechnology sector, particularly in the area of gene therapy and targeted drug delivery.

Collaborations

Daniella collaborates with esteemed colleagues, including Mirko Hennig and David J Lockhart. Their combined expertise fosters a dynamic research environment that enhances the potential for groundbreaking discoveries.

Conclusion

Daniella Ishimaru's contributions to lipid nanoparticle technologies and polynucleotide compositions exemplify her commitment to advancing medical science. Her innovative patents and collaborative efforts continue to pave the way for new therapeutic solutions.